A significant decrease in the number of DUs in favour of sildenafil compared with placebo confirming a sildenafil benefit. PubMed, Ann Rheum Dis, 05/20/2015. (Also see Raynaud's Treatments: Medications)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.